Review
Open access
Jul 2026
Consideration of intersectoral costs and benefits in health economic evaluations of pneumococcal conjugate vaccines: a systematic review
Inclusion of ICBs, except for serotype replacement, showed favorable cost-effectiveness results and provided a framework for identifying the intersectoral costs and benefits for the health economic evaluation of PCVs in children and adults.
Emad Almomani, Musa Dukuray, I. M. van der Putten et al.
· International Journal of Tec... · 0 citations